跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ELIGARD 22.5 MG POWDER FOR SOLUTION FOR INJECTION - SFDA Drug Approval Details
Approvals
/
SFDA
/
ELIGARD 22.5 MG POWDER FOR SOLUTION FOR INJECTION
Authorized
NCE
ELIGARD 22.5 MG POWDER FOR SOLUTION FOR INJECTION
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
a3f128e20489a6a9
Company
Unknown
Type
NCE
Approval Details
Approval Id
a3f128e20489a6a9
Drug Approval Sfda Name
ELIGARD 22.5 MG POWDER FOR SOLUTION FOR INJECTION
Trade Name
ELIGARD 22.5 MG POWDER FOR SOLUTION FOR INJECTION
Generic Name
LEUPRORELIN
Register Number
2504245206
Register Year
2016
Drug Type
NCE
Route Of Administration
Subcutaneous use
Package Type
Vial
Package Size
1
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Restricted
Storage Conditions
store in a refrigerator (2°c – 8°c)
Shelf Life
24 Months
Distribution Site
Hospital
Description Code
7000000746-22.5-100000073868
Price
796.8
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
a3f128e20489a6a9
Type
NCE
Back to SFDA Approvals
